메뉴 건너뛰기




Volumn 37, Issue 2, 2011, Pages 472-474

Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMOXICILLIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DOMPERIDONE; GAMMA GLUTAMYLTRANSFERASE; OMEPRAZOLE; PREDNISOLONE; SILDENAFIL; SITAXSENTAN;

EID: 79951848194     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00091610     Document Type: Letter
Times cited : (28)

References (16)
  • 1
    • 33646255654 scopus 로고    scopus 로고
    • Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan
    • Barst RJ, Langleben D, Badesch D, et al. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol 2006; 47: 2049-2056.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2049-2056
    • Barst, R.J.1    Langleben, D.2    Badesch, D.3
  • 3
    • 40649084619 scopus 로고    scopus 로고
    • Endothelin receptor antagonists in pulmonary arterial hypertension
    • Dupuis J, Hoeper MM. Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008; 31: 407-415.
    • (2008) Eur Respir J , vol.31 , pp. 407-415
    • Dupuis, J.1    Hoeper, M.M.2
  • 4
    • 0036283401 scopus 로고    scopus 로고
    • Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: Open-label pilot study
    • DOI 10.1378/chest.121.6.1860
    • Barst RJ, Rich S, Widlitz A, et al. Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study. Chest 2002; 121: 1860-1868. (Pubitemid 34634407)
    • (2002) Chest , vol.121 , Issue.6 , pp. 1860-1868
    • Barst, R.J.1    Rich, S.2    Widlitz, A.3    Horn, E.M.4    McLaughlin, V.5    McFarlin, J.6
  • 5
    • 69249146238 scopus 로고    scopus 로고
    • Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy
    • Hoeper MM, Olsson KM, Schneider A, et al. Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy. Eur Respir J 2009; 33: 1518-1519.
    • (2009) Eur Respir J , vol.33 , pp. 1518-1519
    • Hoeper, M.M.1    Olsson, K.M.2    Schneider, A.3
  • 6
    • 70349091119 scopus 로고    scopus 로고
    • Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
    • Lavelle A, Sugrue R, Lawler G, et al. Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension. Eur Respir J 2009; 34: 770-771.
    • (2009) Eur Respir J , vol.34 , pp. 770-771
    • Lavelle, A.1    Sugrue, R.2    Lawler, G.3
  • 7
    • 0031045468 scopus 로고    scopus 로고
    • The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs
    • Garcia Rodriguez LA, Wallander MA, Stricker BH. The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs. Br J Clin Pharmacol 1997; 43: 183-188.
    • (1997) Br J Clin Pharmacol , vol.43 , pp. 183-188
    • Garcia Rodriguez, L.A.1    Wallander, M.A.2    Stricker, B.H.3
  • 9
    • 57249086242 scopus 로고    scopus 로고
    • Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States
    • Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-1934.
    • (2008) Gastroenterology , vol.135 , pp. 1924-1934
    • Chalasani, N.1    Fontana, R.J.2    Bonkovsky, H.L.3
  • 10
    • 3142557936 scopus 로고    scopus 로고
    • Acute and clinically relevant drug-induced liver injury: A population case-control study
    • DOI 10.1111/j.1365-2125.2004.02133.x
    • de Abajo FJ, Montero D, Madurga M, et al. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol 2004; 58: 71-80. (Pubitemid 38901470)
    • (2004) British Journal of Clinical Pharmacology , vol.58 , Issue.1 , pp. 71-80
    • De Abajo, F.J.1    Montero, D.2    Madurga, M.3    Garcia, R.L.A.4
  • 11
    • 70349088094 scopus 로고    scopus 로고
    • Liver toxicity: The Achilles' heel of endothelin receptor antagonist therapy?
    • Hoeper MM. Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy? Eur Respir J 2009; 34: 529-530.
    • (2009) Eur Respir J , vol.34 , pp. 529-530
    • Hoeper, M.M.1
  • 12
    • 84866489825 scopus 로고    scopus 로고
    • Date last updated: August 3, Date last accessed: August 3, 2010
    • The electronic Medicines Compendium (eMC). www.medicines.org.uk. Date last updated: August 3, 2010. Date last accessed: August 3, 2010.
    • (2010) The Electronic Medicines Compendium (eMC)
  • 13
    • 70350228380 scopus 로고    scopus 로고
    • Diagnosis, management and prevention of drug-induced liver injury
    • Verma S, Kaplowitz N. Diagnosis, management and prevention of drug-induced liver injury. Gut 2009; 58: 1555-1564.
    • (2009) Gut , vol.58 , pp. 1555-1564
    • Verma, S.1    Kaplowitz, N.2
  • 14
    • 70349406480 scopus 로고    scopus 로고
    • Current concepts of mechanisms in drug-induced hepatotoxicity
    • Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem 2009; 16: 3041-3053.
    • (2009) Curr Med Chem , vol.16 , pp. 3041-3053
    • Russmann, S.1    Kullak-Ublick, G.A.2    Grattagliano, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.